This Wednesday the Supreme Court will hear an attempt by the pro-abortion Biden administration to defend its use of the federal Emergency Medical Treatment and Labor Act [EMTALA] as a lever to force emergency-room doctors to perform abortions in clear violation of Idaho’s Defense of Life Act.
Communications Department
202.626.8825
mediarelations@nrlc.org
Press Room News / Supreme Court
Five Questions I’d Like the Supreme Court Justices to Ask the FDA about Mifepristone
On March 26, the Supreme Court heard oral argument in the F.D.A. v. Alliance for Hippocratic Medicine. The case is the first to address abortion—in this case chemical abortions—since the 2022 Dobbs decision which overturned Roe v. Wade.

What I saw in court
Last week, I helped argue at the U.S. Supreme Court on behalf of pro-life doctors and their patients
A government agency above the law?
The pro-life medical organizations that have long challenged the Food and Drug Administration’s approval and removal of abortion drug safeguards finally had their day in court.

Injuries to Women Largely Ignored in Supreme Court Discussions of FDA Actions on Abortion Pill
In all the arguments that were made in the court Tuesday about “standing” – whether the doctors from the Alliance for Hippocratic Medicine (AHM) as a group or individuals could sufficiently prove past injury or probable injury from the Food and Drug Administration’s lax abortion pill regulations – one thing was noticeably absent: any conclusive refutation of significant safety issues remaining with mifepristone.
More about FDA v. Alliance Hippocratic Medicine and what the Supreme Court asked and heard on Tuesday
At the heart of the discussion before the justices were (a) whether the Alliance had legal standing to file the lawsuit; and (b) the decisions in 2016 and 2021 made by the FDA that greatly weakened regulations of the abortion drug mifepristone.

U.S. Supreme Court Hears Oral Argument in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine
The U.S. Supreme Court heard oral argument today regarding the Food and Drug Administration’s (FDA) decisions in 2016 and 2021 to loosen regulations of the abortion drug mifepristone and whether the challengers have standing to bring their case.

Supreme Court hears arguments in FDA v. Alliance for Hippocratic Medicine
The Supreme Court heard oral arguments today in FDA v. Alliance for Hippocratic Medicine.

Prolife Foundation Files Amici Briefing On Behalf of thousands of Women Injured by Chemical Abortion Pills
A prolife legal foundation has filed an Amici brief to the US Supreme Court on behalf of nearly three thousand women who have experienced injuries from chemical abortion pills.

Ahead of Supreme Court hearing on abortion pill, U.S. bishops call for ‘focused effort of prayer’
The United States Bishops are inviting Catholics to join a focused effort of prayer” for “the end of abortion and the protection of women and preborn children